Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313943) titled 'PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE' on Dec. 18, 2025.
Study Type: Observational
Primary Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition:
Hodgkin or Non-Hodgkin Lymphoma
Recruitment Status: Recruiting
Date of First Enrollment: December 30, 2025
Target Sample Size: 60
Countries of Recruitment:
Germany
Italy
Germany
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07313943
Published by HT Digital Content Services with permission from Health Daily Digest....